Efficiency Evaluation of Listed Enterprises in China"s Biological Industry Based on DEA Model
Author:
Affiliation:

1)College of Information and Electrical Engineering, China Agricultural University, Beijing 100083, China;2)Innovation Driven Development Center, National Development and Reform Commission, Beijing 100037, China

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective With the rapid development of the bio-industry, more and more biological enterprises, mainly biomedical enterprises, have emerged. How to promote the output efficiency of biological enterprises is the most concern of the government and enterprises themselves.Methods This paper constructs a DEA model to evaluate the input-output efficiency of 370 listed companies in China’s biological industry.Results The research results show that the average comprehensive technical efficiency of listed companies in China"s biological industry is 0.596, and there is still much room for improvement.Conclusion The main factor restricting the overall technical efficiency of listed companies in China’s biological industry is pure technical efficiency. Large-scale listed biological companies should optimize investment and reduce redundancy, while smaller-scale listed biological companies need to expand their scale.

    Reference
    Related
    Cited by
Get Citation

DING Jun-Qi, BAI Jing-Yu, LIN Xiao-Feng. Efficiency Evaluation of Listed Enterprises in China"s Biological Industry Based on DEA Model[J]. Progress in Biochemistry and Biophysics,2022,49(2):431-437

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 18,2020
  • Revised:August 17,2020
  • Accepted:September 28,2020
  • Online: February 21,2022
  • Published: February 20,2022